Hormonal and Metabolic Consequences of Sleep Disorders in Young Obese Patients

Obesity Clinical Trial

— SOM  

Official title:

Hormonal and Metabolic Consequences of Sleep Disorders in Young Obese Patients

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT00716222
• Other study ID #: B40320084032
• Status: Recruiting
• Phase: N/A
• First received: July 15, 2008
• Last updated: January 20, 2009
• Start date: May 2008
• Est. completion date: May 2009

Study information

• Verified date: January 2009
• Source: Cliniques universitaires Saint-Luc- Université Catholique de Louvain
• Contact: Veronique VB Beauloye, PhD
• Phone: +3227641370
• Email: Veronique.Beauloye[@]uclouvain.be
• Is FDA regulated: No
• Health authority: Belgium: Institutional Review Board
• Study type: Observational

Clinical Trial Summary

There is a well-documented relationship between short sleep duration and high body mass index (BMI). The mechanism linking short sleep duration and weight gain is unknown. Current studies in healthy young volunteers have shown that experimental sleep restriction is associated with dysregulation of the neuroendocrine control of appetite and with alterations in glucose metabolism. The goal of our study is to determine the metabolic and hormonal modifications induced by chronic sleep curtailment in obese adolescents and young adults and to observe if short sleep is a negative prognostic factor in their weight evolution.

Description:

The main purpose of the study is investigate whether the concentrations of 2 hormones that regulate appetite (leptin, ghrelin), cytokines (TNF-a, IL-6) and CRP are modified in obese adolescents and young adults who had sleep disorders in comparison to obese adolescents and young adults who sleep longer.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 70
• Est. completion date: May 2009
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 13 Years to 25 Years

Eligibility

Inclusion Criteria:

• 13-25 years old

• BMI > 30 kg/m2 (If adolescents aged under 18 years: BMI equivalent to a BMI for age and sex to a BMI of 30, according to the Cole et al. obesity criteria).

Exclusion Criteria:

• Infection

• Liver disease

• Chronic inflammatory disease

• Endocrine disease

• Use of drugs that alter the sensitivity of insulin

Study Design

Observational Model: Cohort, Time Perspective: Cross-Sectional

Related Conditions & MeSH terms

• Obesity
• Parasomnias
• Sleep Disorders

Locations

Country	Name	City	State
Belgium	Cliniques Universitaires Saint Luc	Brussels

Sponsors (1)

Lead Sponsor	Collaborator
Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Country where clinical trial is conducted

Belgium,